1Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin ,2011 ,61 (2) :69-90.
2Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come [J]. CA Cancer J Clin,2010 ,60( 4) :244-272.
3Beezhold KJ, Castranova V, Chen F. Microprocessor of microRNAs: regulation and potential for therapeutic intervention [J]. Mol Cancer ,2010 ,9: 134.
4Kassouf W, Black PC, Tuziak T, et al. Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer[J].J Urol,2008,179(1) :353-358.
5Colquhoun AJ, Sundar S, Rajjayabun PH, et al. Epidermal growth factor receptor status predicts local response to radical radiotherapy in muscle-invasive bladder cancer [J] . Clin Oncol (R Coli Radi- 01) ,2006,18(9) :702-709.
7Slaton JW, Milikan R, Inoue K, et al. Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy[J].J Urol,2004,171 (2 Pt 1) :570-574.
8Mitra AP, Datar RH, Cote RJ. Molecular pathways in invasive blad- der cancer: new insight into mechanisms, progression, and target identification [J]. J Clin 0ncol,2006,24 ( 35 ) :5552-5564.
10Lu J ,Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers [J] . Nature, 2005,435 (7043) :834-838.
二级参考文献9
1Takahashi C, Sheng Z, Horan T P, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK[J]. Proc Natl Acad Sci USA,1998,95:13221-13226.
2Oh J, Takahashi R, Kondo S, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis[J]. Cell, 2001,107 : 789-800.
3Wu X, Gan B, Yoo Y, et al. FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation[J]. Dev Cell, 2005,9 : 185-196.
4Masui T, Doi R, Koshiba T, et al. RECK expression in pancreatic cancer:its correlation with lower invasiveness and better prognosis[J]. Clin Cancer Res,2003,9 : 1779-1784.
5Cho C Y, Wang J H, Chang H C, et al. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells[J]. J Cell Physiol, 2007, 213 : 65- 69.
6Chang H C, Cho C Y, Hung W C. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer[J]. Cancer Sci, 2007,98 : 169-173.
7Takenaka K, Ishikawa S, Kawano Y, et al. Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer[J]. Eur J Cancer, 2004, 40 : 1617-1623.
8Kanayama H, Yokota K, Kurokawa Y, et al. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metal loproteinase-2 expression in bladder cancer[J]. Cancer, 1998 82:1359-1366.
9Ozdemir E, Kakehi Y, Okuno H, et al. Role of matrix metal loproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas[J]. J Urol, 1999,161 : 1359-1363.
